Cleared Traditional

K172582 - EUROIMMUN IFA Granulocyte Mosaic™ EUROPattern and EUROIMMUN EUROPLUS Granulocyte Mosaic™ EUROPattern (FDA 510(k) Clearance)

May 2018
Decision
269d
Days
Class 2
Risk

K172582 is an FDA 510(k) clearance for the EUROIMMUN IFA Granulocyte Mosaic™ EUROPattern and EUROIMMUN EUROPLUS Granulocyte Mosaic™ EUROPattern. This device is classified as a Test System, Antineutrophil Cytoplasmic Antibodies (anca) (Class II - Special Controls, product code MOB).

Submitted by Euroimmun Us, Inc. (Mountain Lakes, US). The FDA issued a Cleared decision on May 24, 2018, 269 days after receiving the submission on August 28, 2017.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5660.

Submission Details

510(k) Number K172582 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 28, 2017
Decision Date May 24, 2018
Days to Decision 269 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement

Device Classification

Product Code MOB - Test System, Antineutrophil Cytoplasmic Antibodies (anca)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5660